FFCP PHASE1:Mm9::chr2:155572913..155572925,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=97|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr2:155572913..155572925,+|id=chr2:155572913..155572925,+|ontology_enrichment_celltype=CL:0000349!4.98e-22!3;CL:0000351!4.98e-22!3|ontology_enrichment_celltype_v019_2=CL:0000349,1.33e-65,3;CL:0000351,1.33e-65,3|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0000358!4.98e-22!3;UBERON:0000307!4.98e-22!3;UBERON:0005631!2.85e-21!3;UBERON:0000478!2.85e-21!3;UBERON:0000158!2.85e-21!3;UBERON:0001987!8.97e-15!2;UBERON:0003124!8.97e-15!2;UBERON:0004340!8.97e-15!2;UBERON:0000305!3.50e-08!1;UBERON:0001723!4.80e-08!1;UBERON:0001033!4.80e-08!1;UBERON:0010056!4.80e-08!1;UBERON:0005795!7.72e-08!4;UBERON:0000995!7.72e-08!4|ontology_enrichment_uberon_v019_2=UBERON:0000358,1.33e-65,3;UBERON:0000307,1.33e-65,3;UBERON:0007010,1.33e-65,3;UBERON:0001987,5.17e-12,2;UBERON:0003124,5.17e-12,2;UBERON:0004340,5.17e-12,2;UBERON:0005631,1.88e-08,3;UBERON:0000478,1.88e-08,3;UBERON:0000158,1.88e-08,3|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.216491041011214,0,0,0,0,0,0,0,0,0,0,0,0.494389935468748,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.983528546038072,0,0.160550589987792,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.50949465803873,0.42366414172764,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0826534557253359,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.100966449948148,0,0.100826185136841,0,0,0,0.226730383615211,9.10142408833665,23.8638858581205,38.7813463801021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr2:155572913..155572925,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=97 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr2:155572913..155572925,+ | |||
|description=CAGE_peak_at_chr2:155572913..155572925,+ | |||
|id=chr2:155572913..155572925,+ | |||
|ontology_enrichment_celltype=CL:0000349!4.98e-22!3;CL:0000351!4.98e-22!3 | |||
|ontology_enrichment_celltype_v019_2=CL:0000349,1.33e-65,3;CL:0000351,1.33e-65,3 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0000358!4.98e-22!3;UBERON:0000307!4.98e-22!3;UBERON:0005631!2.85e-21!3;UBERON:0000478!2.85e-21!3;UBERON:0000158!2.85e-21!3;UBERON:0001987!8.97e-15!2;UBERON:0003124!8.97e-15!2;UBERON:0004340!8.97e-15!2;UBERON:0000305!3.50e-08!1;UBERON:0001723!4.80e-08!1;UBERON:0001033!4.80e-08!1;UBERON:0010056!4.80e-08!1;UBERON:0005795!7.72e-08!4;UBERON:0000995!7.72e-08!4 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000358,1.33e-65,3;UBERON:0000307,1.33e-65,3;UBERON:0007010,1.33e-65,3;UBERON:0001987,5.17e-12,2;UBERON:0003124,5.17e-12,2;UBERON:0004340,5.17e-12,2;UBERON:0005631,1.88e-08,3;UBERON:0000478,1.88e-08,3;UBERON:0000158,1.88e-08,3 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.216491041011214,0,0,0,0,0,0,0,0,0,0,0,0.494389935468748,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.983528546038072,0,0.160550589987792,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.50949465803873,0.42366414172764,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0826534557253359,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.100966449948148,0,0.100826185136841,0,0,0,0.226730383615211,9.10142408833665,23.8638858581205,38.7813463801021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr2:155572913..155572925,+ | |||
}} |
Latest revision as of 08:35, 4 August 2015
Short description: | p@chr2:155572913..155572925, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr2:155572913..155572925, + |
Coexpression cluster: | MCL_coexpression_mm9:97 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
extraembryonic cell | 1.33e-65 | 3 |
trophoblast cell | 1.33e-65 | 3 |
Ontology term | p-value | n |
---|---|---|
blastocyst | 1.33e-65 | 3 |
blastula | 1.33e-65 | 3 |
cleaving embryo | 1.33e-65 | 3 |
placenta | 5.17e-12 | 2 |
chorion | 5.17e-12 | 2 |
allantois | 5.17e-12 | 2 |
extraembryonic membrane | 1.88e-08 | 3 |
extraembryonic structure | 1.88e-08 | 3 |
membranous layer | 1.88e-08 | 3 |